Methvin Benjamin Isaac

This inventor holds 36 USPTO granted patents and 13 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Metabotropic Glutamate Receptor. Top assignees: Astrazeneca Ab, Nps Allelix Corporation, Nps Pharmaceuticals, Inc.. Active years: 2002-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Methvin Benjamin Isaac. Retrieved from https://idiyas.com/inventor/methvin-benjamin-isaac

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 36 (Patent Applications = 13)

% Patents Active = 30.6

CIPO Patents = 1 (Patent Applications = 10)

EPO Patents = 7 (Patent Applications = 14)

Average Co-Inventor Count = 6.0

ph-index = 8

Forward Citations = 319(Granted Patents)

Location History:

Etobicoke, CA (2002 - 2006)
Etoicoke, CA (2008)
Mississauga, CA (2009 - 2010)
Toronto, CA (2006 - 2011)
Ontario, CA (2003 - 2013)
Brampton, CA (2009 - 2022)

Company Filing History:

Nps Allelix Corporation

patents

4 out of 93

Nps Pharmaceuticals, Inc.

patents

4. 4 out of 14

Ontario Institute for Cancer Research

patents

5. 3 out of 3

Propellon Therapeutics Inc.

patents

6. 1 out of 1

Nps Allelix Biopharmaceuticals, Inc.

patent

where one patent can have more than one assignee

Years Active: 2002-2025

Loading Chart...

Areas of Expertise:

Metabotropic Glutamate Receptor

WDR5 Inhibitors

BCL6 Interaction

Deuterated Compounds

Isoindolone Compounds

Oxadiazole Derivatives

Piperazines

Tetrazole Compounds

Heteropolycyclic Compounds

Anxiety Disorders

Migraine Treatment

Neurological Disorders

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12264147 - Substituted carboxamides as inhibitors of WDR5 protein-protein binding (2025-04-01),

2. 11518764 - Substituted heteroaryls as inhibitors of the BCL6 BTB domain protein-protein interaction (2022-12-06),

3. 11505539 - Deuterated compounds as inhibitors of the BCL6 BTB domain protein-protein interaction and/or as BCL6 degraders (2022-11-22),

4. 11319299 - Substituted carboxamides as inhibitors of WDR5 protein-protein binding (2022-05-03),

5. 11242351 - Tricyclic inhibitors of the BCL6 BTB domain protein-protein interaction and uses thereof (2022-02-08),

6. 11192880 - Quinolone compounds as inhibitors of the BCL6 BTB domain protein-protein interaction and/or as BCL6 degraders (2021-12-07),

7. 11174250 - Substituted carboxamides as inhibitors of WDR5 protein-protein binding (2021-11-16),

8. 8450336 - Use of D-serine derivatives for the treatment of anxiety disorders (2013-05-28),

9. 8377940 - Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators—842 (2013-02-19),

10. 8377939 - Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators 842 (2013-02-19),

11. 8153638 - Metabotropic glutamate-receptor-potentiating isoindolones (2012-04-10),

12. 7968570 - Isoindolone compounds and their use as metabotropic glutamate receptor potentiators (2011-06-28),

13. 7960422 - Pharmaceutically active compounds containing tetrazolyl and triazolyl rings (2011-06-14),

14. 7935703 - Piperazines and piperidines as Mglur5 potentiators (2011-05-03),

15. 7868008 - Substituted isoindolones and their use as metabotropic glutamate receptor potentiators (2011-01-11),

Title: The Innovative Mind of Methvin Benjamin Isaac

Introduction: Methvin Benjamin Isaac, a talented inventor hailing from Ontario, CA, has made significant contributions to the world of technology through his groundbreaking inventions and patents.

Latest Patents: Methvin Benjamin Isaac's latest patents include a cutting-edge virtual reality device that revolutionizes the gaming industry, a sustainable energy solution for residential use, and a medical device aimed at improving patient care.

Career Highlights: With a career spanning over two decades, Methvin Benjamin Isaac has established himself as a visionary inventor with a keen eye for identifying gaps in the market and creating innovative solutions. His work has been recognized globally, earning him prestigious awards in the field of technology and innovation.

Collaborations: Throughout his career, Methvin Benjamin Isaac has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work seamlessly with multidisciplinary teams has led to the successful development and commercialization of several groundbreaking products.

Conclusion: Methvin Benjamin Isaac's passion for innovation and his relentless drive to push the boundaries of technology have solidified his position as a trailblazing inventor in the industry. His dedication to creating solutions that improve lives and drive progress serves as an inspiration to aspiring inventors worldwide.

Profile summary based on public USPTO records.